Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma [Neuro-oncology]

Conclusion
The results of this analysis do not justify the use of VPA or LEV for reasons other than seizure control in patients with newly diagnosed glioblastoma outside clinical trials.

Source: Journal of Clinical Oncology - February 22, 2016 Category: Cancer & Oncology Authors: Happold, Gorlia, Chinot, Gilbert, Nabors, Wick, Pugh, Hegi, Cloughesy, Roth, Reardon, Perry, Mehta, Stupp, Weller Tags: Brain Tumors, Radiation, Chemotherapy Neuro-oncology Source Type: research